PMID- 23508652 OWN - NLM STAT- MEDLINE DCOM- 20140409 LR - 20151119 IS - 1477-0970 (Electronic) IS - 1352-4585 (Linking) VI - 19 IP - 9 DP - 2013 Aug TI - Clinically silent PML and prolonged immune reconstitution inflammatory syndrome in a patient with multiple sclerosis treated with natalizumab. PG - 1226-9 LID - 10.1177/1352458513481010 [doi] AB - We report the case of a woman with natalizumab-treated multiple sclerosis (MS) and clinically silent progressive multifocal leukoencephalopathy (PML) with an unusually long preclinical phase, followed by acute symptoms due to development of immune reconstitution inflammatory syndrome (IRIS). Furthermore, the course of the IRIS was prolonged and continued to progress even five months after natalizumab treatment was ceased. This case shows that PML and IRIS can have a considerably variable course in natalizumab-treated MS patients and underlines the need for PML screening in JC virus antibody-positive patients in order to detect clinically silent cases. FAU - Blinkenberg, Morten AU - Blinkenberg M AD - Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital, Rigshospitalet, Denmark. blink@dadlnet.dk FAU - Sellebjerg, Finn AU - Sellebjerg F FAU - Leffers, Anne-Mette AU - Leffers AM FAU - Madsen, Camilla Gobel AU - Madsen CG FAU - Sorensen, Per Soelberg AU - Sorensen PS LA - eng PT - Case Reports PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20130318 PL - England TA - Mult Scler JT - Multiple sclerosis (Houndmills, Basingstoke, England) JID - 9509185 RN - 0 (Antibodies, Monoclonal, Humanized) RN - 0 (Natalizumab) SB - IM MH - Adenocarcinoma/complications MH - Antibodies, Monoclonal, Humanized/*therapeutic use MH - Breast Neoplasms/complications MH - Cerebellum/pathology MH - Female MH - Humans MH - Immune Reconstitution Inflammatory Syndrome/*complications/pathology/physiopathology MH - JC Virus MH - Leukoencephalopathy, Progressive Multifocal/*complications/pathology/physiopathology MH - Magnetic Resonance Imaging MH - Male MH - Middle Aged MH - Multiple Sclerosis, Relapsing-Remitting/*complications/drug therapy/physiopathology MH - Natalizumab OTO - NOTNLM OT - IRIS OT - PML OT - multiple sclerosis OT - natalizumab EDAT- 2013/03/20 06:00 MHDA- 2014/04/10 06:00 CRDT- 2013/03/20 06:00 PHST- 2013/03/20 06:00 [entrez] PHST- 2013/03/20 06:00 [pubmed] PHST- 2014/04/10 06:00 [medline] AID - 1352458513481010 [pii] AID - 10.1177/1352458513481010 [doi] PST - ppublish SO - Mult Scler. 2013 Aug;19(9):1226-9. doi: 10.1177/1352458513481010. Epub 2013 Mar 18.